Compare IBRX & AWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IBRX | AWI |
|---|---|---|
| Founded | 2014 | 1860 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Plastic Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 7.0B |
| IPO Year | 2015 | 1994 |
| Metric | IBRX | AWI |
|---|---|---|
| Price | $7.26 | $165.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | $12.57 | ★ $208.50 |
| AVG Volume (30 Days) | ★ 22.2M | 502.3K |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 0.82% |
| EPS Growth | ★ 38.71 | 17.61 |
| EPS | N/A | ★ 7.08 |
| Revenue | $113,288,000.00 | ★ $1,620,800,000.00 |
| Revenue This Year | $88.59 | $10.25 |
| Revenue Next Year | $131.15 | $6.72 |
| P/E Ratio | ★ N/A | $23.34 |
| Revenue Growth | ★ 668.31 | 12.11 |
| 52 Week Low | $1.83 | $122.37 |
| 52 Week High | $12.43 | $206.08 |
| Indicator | IBRX | AWI |
|---|---|---|
| Relative Strength Index (RSI) | 46.21 | 41.52 |
| Support Level | $5.89 | $162.50 |
| Resistance Level | $8.28 | $170.29 |
| Average True Range (ATR) | 0.94 | 4.19 |
| MACD | -0.21 | 0.73 |
| Stochastic Oscillator | 25.33 | 45.58 |
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
Armstrong World Industries Inc designs and manufactures exterior architectural applications, including ceilings, specialty walls, and exterior metal solutions, using materials such as mineral fiber, fiberglass, metal, felt, architectural resin and glass, wood, wood fiber, and glass-reinforced-gypsum. Its segments include Mineral Fiber, which produces suspended mineral fiber and fiberglass ceiling systems and includes results from the Worthington Armstrong Venture (WAVE) for ceiling suspension system (grid) products; Architectural Specialties, which designs, produces, and sources specialty ceilings, walls, and other architectural applications for commercial settings, with revenues mainly project driven; and Unallocated Corporate. The company operates in the United States and Canada.